LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Promiscuity of in vitro secondary pharmacology assays and implications for lead optimization strategies.

Photo by diana_pole from unsplash

We conducted an analysis on screening data generated from 1445 compounds against a panel of 130 enzymes, ion channels and receptors to assess secondary pharmacological risks. Hit rates of these… Click to show full abstract

We conducted an analysis on screening data generated from 1445 compounds against a panel of 130 enzymes, ion channels and receptors to assess secondary pharmacological risks. Hit rates of these targets as well as physicochemical properties for those hits were evaluated. A majority of targets yielded hits with higher clogP, molecular weight, and more basic character than inactive compounds. Although most targets favored lipophilic hits, the average clogP of hits at a given target did not correlate with its hit rate. Furthermore, a matched pair analysis was completed to determine structural changes that impacted off-target activities. A correlation of binding assays used in this analysis illustrated that some pharmacologically related binding assays are highly correlative and may be substituted for a smaller set of surrogate assays.

Keywords: secondary pharmacology; assays implications; pharmacology assays; pharmacology; vitro secondary; promiscuity vitro

Journal Title: Journal of medicinal chemistry
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.